Cargando…
The variants question: What is the problem?
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) originated in Wuhan, China in early December 2019 has rapidly widespread worldwide. Over the course of the pandemic, due to the advance of whole‐genome sequencing technologies, an unprecedented number of genomes have been generated, pr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426965/ https://www.ncbi.nlm.nih.gov/pubmed/34255352 http://dx.doi.org/10.1002/jmv.27196 |
_version_ | 1783750116614602752 |
---|---|
author | Zella, Davide Giovanetti, Marta Benedetti, Francesca Unali, Francesco Spoto, Silvia Guarino, Michele Angeletti, Silvia Ciccozzi, Massimo |
author_facet | Zella, Davide Giovanetti, Marta Benedetti, Francesca Unali, Francesco Spoto, Silvia Guarino, Michele Angeletti, Silvia Ciccozzi, Massimo |
author_sort | Zella, Davide |
collection | PubMed |
description | The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) originated in Wuhan, China in early December 2019 has rapidly widespread worldwide. Over the course of the pandemic, due to the advance of whole‐genome sequencing technologies, an unprecedented number of genomes have been generated, providing both invaluable insights into the ongoing evolution and epidemiology of the virus and allowing the identification of hundreds of circulating genetic variants during the pandemic. In recent months variants of SARS‐CoV‐2 that have an increased number of mutations on the Spike protein have brought concern all over the world. These have been called “variants of concerns” (VOCs), and/or “variants of interests” (VOIs) as it has been suggested that their genome mutations might impact transmission, immune control, and virulence. Tracking the spread of emerging SARS‐CoV‐2 variants is crucial to inform public health efforts and control the ongoing pandemic. In this review, a concise characterization of the SARS‐CoV‐2 mutational patterns of the main VOCs and VOIs circulating and cocirculating worldwide has been presented to determine the magnitude of the SARS‐CoV‐2 threat to better understand the virus genetic diversity and its potential impact on vaccination strategy. |
format | Online Article Text |
id | pubmed-8426965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84269652021-09-09 The variants question: What is the problem? Zella, Davide Giovanetti, Marta Benedetti, Francesca Unali, Francesco Spoto, Silvia Guarino, Michele Angeletti, Silvia Ciccozzi, Massimo J Med Virol Reviews The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) originated in Wuhan, China in early December 2019 has rapidly widespread worldwide. Over the course of the pandemic, due to the advance of whole‐genome sequencing technologies, an unprecedented number of genomes have been generated, providing both invaluable insights into the ongoing evolution and epidemiology of the virus and allowing the identification of hundreds of circulating genetic variants during the pandemic. In recent months variants of SARS‐CoV‐2 that have an increased number of mutations on the Spike protein have brought concern all over the world. These have been called “variants of concerns” (VOCs), and/or “variants of interests” (VOIs) as it has been suggested that their genome mutations might impact transmission, immune control, and virulence. Tracking the spread of emerging SARS‐CoV‐2 variants is crucial to inform public health efforts and control the ongoing pandemic. In this review, a concise characterization of the SARS‐CoV‐2 mutational patterns of the main VOCs and VOIs circulating and cocirculating worldwide has been presented to determine the magnitude of the SARS‐CoV‐2 threat to better understand the virus genetic diversity and its potential impact on vaccination strategy. John Wiley and Sons Inc. 2021-07-28 2021-12 /pmc/articles/PMC8426965/ /pubmed/34255352 http://dx.doi.org/10.1002/jmv.27196 Text en © 2021 The Authors. Journal of Medical Virology Published by Wiley Periodicals LLC https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Zella, Davide Giovanetti, Marta Benedetti, Francesca Unali, Francesco Spoto, Silvia Guarino, Michele Angeletti, Silvia Ciccozzi, Massimo The variants question: What is the problem? |
title | The variants question: What is the problem? |
title_full | The variants question: What is the problem? |
title_fullStr | The variants question: What is the problem? |
title_full_unstemmed | The variants question: What is the problem? |
title_short | The variants question: What is the problem? |
title_sort | variants question: what is the problem? |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426965/ https://www.ncbi.nlm.nih.gov/pubmed/34255352 http://dx.doi.org/10.1002/jmv.27196 |
work_keys_str_mv | AT zelladavide thevariantsquestionwhatistheproblem AT giovanettimarta thevariantsquestionwhatistheproblem AT benedettifrancesca thevariantsquestionwhatistheproblem AT unalifrancesco thevariantsquestionwhatistheproblem AT spotosilvia thevariantsquestionwhatistheproblem AT guarinomichele thevariantsquestionwhatistheproblem AT angelettisilvia thevariantsquestionwhatistheproblem AT ciccozzimassimo thevariantsquestionwhatistheproblem AT zelladavide variantsquestionwhatistheproblem AT giovanettimarta variantsquestionwhatistheproblem AT benedettifrancesca variantsquestionwhatistheproblem AT unalifrancesco variantsquestionwhatistheproblem AT spotosilvia variantsquestionwhatistheproblem AT guarinomichele variantsquestionwhatistheproblem AT angelettisilvia variantsquestionwhatistheproblem AT ciccozzimassimo variantsquestionwhatistheproblem |